scholarly article | Q13442814 |
P356 | DOI | 10.1007/S10067-017-3713-7 |
P698 | PubMed publication ID | 28589322 |
P50 | author | Dafna D. Gladman | Q37605821 |
P2093 | author name string | Murray B Urowitz | |
Jiandong Su | |||
Roaa Aljohani | |||
P2860 | cites work | The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 |
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus | Q29614922 | ||
Factors associated with low bone mineral density in female patients with systemic lupus erythematosus | Q31984501 | ||
Systemic lupus erythematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospectively | Q33561741 | ||
Atherosclerosis and systemic lupus erythematosus | Q34108806 | ||
Hydroxychloroquine treatment in a community-based cohort of patients with systemic lupus erythematosus | Q34162739 | ||
Contributions of observational cohort studies in systemic lupus erythematosus: the university of toronto lupus clinic experience | Q36142451 | ||
Utilization of health services and prescription patterns among lupus patients followed by primary care physicians and rheumatologists in Puerto Rico | Q37327014 | ||
Glucocorticoid use and abuse in SLE. | Q37978291 | ||
Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus | Q38454380 | ||
The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus | Q40974327 | ||
Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXVIII. Factors predictive of thrombotic events | Q41911950 | ||
Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual | Q41912319 | ||
Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort | Q41917167 | ||
The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs. | Q41924668 | ||
Prevention of glucocorticoid-induced osteoporosis: experience in a managed care setting | Q43616354 | ||
Health care and burden of illness in systemic lupus erythematosus compared to rheumatoid arthritis: results from the National Database of the German Collaborative Arthritis Centres. | Q44089331 | ||
Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients | Q46366994 | ||
Effect of antimalarial agents on the fasting lipid profile in systemic lupus erythematosus. | Q51553735 | ||
Natural history of hypercholesterolemia in systemic lupus erythematosus | Q73101137 | ||
Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation | Q73115074 | ||
Role of specialty care in the management of patients with systemic lupus erythematosus | Q74299772 | ||
Systemic lupus erythematosus disease activity index 2000 | Q77624632 | ||
P433 | issue | 8 | |
P921 | main subject | systemic lupus erythematosus | Q1485 |
P304 | page(s) | 1773-1778 | |
P577 | publication date | 2017-06-06 | |
P1433 | published in | Clinical Rheumatology | Q15754927 |
P1476 | title | Comparison of systemic lupus erythematosus (SLE) patients managed early after diagnosis in specialty versus community care clinics | |
P478 | volume | 36 |
Search more.